Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bone marrow mesenchymal stromal cells-derived extracellular vesicles
- Development stage
- Phase 2
- Lead developer
- EV Biologics
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Cell Therapies
- Administration
- Intravenous, Local Injection (e.g., Intra-articular)
01
Overview
Bone marrow mesenchymal stromal cells-derived extracellular vesicles (BM-MSC-EVs) are nanoscale lipid bilayer-enclosed particles released by bone marrow mesenchymal stromal (or stem) cells. These vesicles include exosomes and microvesicles and act as mediators of intercellular communication by transferring proteins, mRNA, non-coding RNAs, and lipids to recipient cells. BM-MSC-EVs exert similar biological effects as their parental MSCs through mechanisms such as receptor-ligand interactions, direct membrane fusion, or endocytosis/phagocytosis. They have shown therapeutic efficacy in various preclinical models for a range of diseases due to their ability to modulate immune responses, promote tissue repair/regeneration, and deliver bioactive molecules. Their use is being explored both as substitutes for intact cell therapies and as vehicles for targeted drug delivery[1][2].
- Other names
- bone marrow MSC-derived EVsbone marrow mesenchymal stem cell-derived extracellular vesiclesBM-MSC-EVs
Beyond the preview
Go deeper on bone marrow mesenchymal stromal cells-derived extracellular vesicles.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bone marrow mesenchymal stromal cells-derived extracellular vesicles.